Found: 33
Select item for more details and to access through your institution.
Enoxaparin decreases serum MCP-1 concentration during haemodialysis—preliminary report.
- Published in:
- NDT Plus, 2009, v. 2, n. 5, p. 429, doi. 10.1093/ndtplus/sfp060
- By:
- Publication type:
- Article
Unexpected and striking effect of heparin-free dialysis on cytokine release.
- Published in:
- International Urology & Nephrology, 2017, v. 49, n. 8, p. 1447, doi. 10.1007/s11255-017-1589-8
- By:
- Publication type:
- Article
Soluble thrombomodulin is associated with viral hepatitis, blood pressure, and medications in haemodialysis patients.
- Published in:
- Nephrology Dialysis Transplantation, 2001, v. 16, n. 4, p. 787, doi. 10.1093/ndt/16.4.787
- By:
- Publication type:
- Article
Effects of Enoxaparin on Intravascular Sclerostin Release in Healthy Men.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ketanserin and erythropoiesis in hemodialysis patients with polycystic kidneys.
- Published in:
- 1996
- By:
- Publication type:
- Letter
Enoxaparin decreases serum MCP-1 concentration during haemodialysis—preliminary report.
- Published in:
- Nephrology Dialysis Transplantation, 2009, v. 2, n. 5, p. 429, doi. 10.1093/ndtplus/sfp060
- By:
- Publication type:
- Article
Enoxaparin but not unfractionated heparin causes a dose-dependent increase in plasma TGF-{beta}1 during haemodialysis: a cross-over study.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. 6, p. 1690, doi. 10.1093/ndt/gfm082
- By:
- Publication type:
- Article
The periodontal status of pre-dialysis chronic kidney disease and maintenance dialysis patients.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. 2, p. 457
- By:
- Publication type:
- Article
Tissue factor and its inhibitor in human non-crescentic glomerulonephritis—immunostaining vs plasma and urinary levels.
- Published in:
- Nephrology Dialysis Transplantation, 2006, v. 21, n. 12, p. 3450, doi. 10.1093/ndt/gfl365
- By:
- Publication type:
- Article
Myeloperoxidase up-regulation during haemodialysis: is heparin the missing link?
- Published in:
- Nephrology Dialysis Transplantation, 2006, v. 21, n. 4, p. 1128, doi. 10.1093/ndt/gfl002
- By:
- Publication type:
- Article
Unexpected effect of haemodialysis on salivary hepatocyte growth factor.
- Published in:
- Nephrology Dialysis Transplantation, 2005, v. 20, n. 12, p. 2869, doi. 10.1093/ndt/gfi129
- By:
- Publication type:
- Article
Liver disease <it>vs</it> systemic inflammation in haemodialysis patients.
- Published in:
- Nephrology Dialysis Transplantation, 2005, v. 20, n. 6, p. 1277, doi. 10.1093/ndt/gfh804
- By:
- Publication type:
- Article
Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in haemodialysis patients.
- Published in:
- Nephrology Dialysis Transplantation, 2002, v. 17, n. 4, p. 637, doi. 10.1093/ndt/17.4.637
- By:
- Publication type:
- Article
Renal function, proteinuria and ACE‐inhibitor therapy as determinants of plasma levels of endothelial markers.
- Published in:
- Nephrology Dialysis Transplantation, 2002, v. 17, n. 3, p. 526, doi. 10.1093/ndt/17.3.526
- By:
- Publication type:
- Article
Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre‐dialysis blood pressure and the acute phase response.
- Published in:
- Nephrology Dialysis Transplantation, 2001, v. 16, n. 7, p. 1442, doi. 10.1093/ndt/16.7.1442
- By:
- Publication type:
- Article
STAPHYLOCOCCAL SCALDED SKIN SYNDROME IN THE COURSE OF LUPUS NEPHRITIS.
- Published in:
- Nephrology, 2008, v. 13, n. 3, p. 265, doi. 10.1111/j.1440-1797.2007.00904.x
- By:
- Publication type:
- Article
Membranous nephropathy: anti-PLA<sub>2</sub>R-guided diagnosis versus clinical reality.
- Published in:
- Polish Archives of Internal Medicine, 2019, v. 129, p. 39
- By:
- Publication type:
- Article
Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy.
- Published in:
- Endocrine (1355008X), 2011, v. 40, n. 1, p. 95, doi. 10.1007/s12020-011-9446-5
- By:
- Publication type:
- Article
Full-Length TFPI Release by Heparinoid Sulodexide.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2010, v. 16, n. 4, p. 485, doi. 10.1177/1076029609338048
- By:
- Publication type:
- Article
Effect of Sulodexide on Plasma Transforming Growth Factor-β1 in Healthy Volunteers.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2010, v. 16, n. 1, p. 60, doi. 10.1177/1076029608326170
- By:
- Publication type:
- Article
Intravenous and Oral Sulodexide Versus Coagulation Activation Markers in Humans.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2009, v. 15, n. 5, p. 596, doi. 10.1177/1076029609333674
- By:
- Publication type:
- Article
Pleiotropic Effects of Heparin and Heparinoids in Peritoneal Dialysis.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2009, v. 15, n. 1, p. 92, doi. 10.1177/1076029607304722
- By:
- Publication type:
- Article
Endothelial Injury Markers With High-dose Intravenous Iron Therapy in Renal Failure.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2004, v. 10, n. 4, p. 403, doi. 10.1177/107602960401000416
- By:
- Publication type:
- Article
Activin A/Follistatin System: Another Link to Heparin-induced Osteoporosis?
- Published in:
- 2004
- By:
- Publication type:
- Letter
Short-term Erythropoietin Therapy Does Not Increase Plasma Tissue Factor and its Inhibitor Levels in Hemodialysis Patients.
- Published in:
- 2003
- By:
- Publication type:
- Letter
Hepatocyte Growth Factor: A Possible Mediator of Heparin-induced Osteoporosis?
- Published in:
- 2003
- By:
- Publication type:
- Letter
Tissue Factor and Thrombomodulin in Hemodialysis Patients: Associations with Endothelial Injury, Liver Disease, and Erythropoietin Therapy.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2002, v. 8, n. 4, p. 359, doi. 10.1177/107602960200800408
- By:
- Publication type:
- Article
Effect of Hemodialysis on Plasma Levels of Vascular Endothelial Markers.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2002, v. 8, n. 3, p. 245, doi. 10.1177/107602960200800308
- By:
- Publication type:
- Article
Increased Soluble Thrombomodulin Does Not Always Indicate Endothelial Injury.
- Published in:
- 2002
- By:
- Publication type:
- Letter
Effects of Recombinant Erythropoietin Therapy on Circulating Endothelial Markers in Hemodialysis Patients.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2002, v. 8, n. 1, p. 77, doi. 10.1177/107602960200800111
- By:
- Publication type:
- Article
Plasma Fibrinogen Level Is an Important Determinant of Prolonged Euglobulin Clot Lysis Time in Hemodialysis Patients.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2001, v. 7, n. 4, p. 296, doi. 10.1177/107602960100700408
- By:
- Publication type:
- Article
Plasma activin A in hemodialysis patients: Does brand of immunoassay matter?
- Published in:
- 2004
- By:
- Publication type:
- Letter
DIALYSIS – TRANSPLANTATION Activation of hepatocyte growth factor/activin A/follistatin system during hemodialysis: Role of heparin.
- Published in:
- Kidney International, 2003, v. 64, n. 6, p. 2229, doi. 10.1046/j.1523-1755.2003.00307.x
- By:
- Publication type:
- Article